Sfoglia per RIVISTA
CLINICOECONOMICS AND OUTCOMES RESEARCH : CEOR
Collezione AOU Città della Salute di Torino
Items : 1
Cost-Utility Analysis Comparing Pegcetacoplan to Anti-C5 Monoclonal Antibodies in the Treatment of Paroxysmal Nocturnal Hemoglobinuria. in ClinicoEconomics and outcomes research : CEOR / Clinicoecon Outcomes Res. 2024 Apr 11;16:225-232. doi: 10.2147/CEOR.S442906. eCollection 2024.
2024
AOU Città della Salute di Torino
Teruzzi C; Ciccarone A; Moumene S; Martone N; Notaro R; Bruno GM; Freilone R; Di Matteo S; Colombo GL;